Kenneth Dipietro's Net Worth

$6.76 Million

Estimate Recalculated Jul 3, 2024 03:08PM EST

Who is Kenneth Dipietro?

Kenneth Dipietro has an estimated net worth of $6.76 Million. This is based on reported shares across multiple companies, which include BIOGEN INC., Cerevel Therapeutics Holdings, Inc., and INVIVO THERAPEUTICS HOLDINGS CORP..

SEC CIK

Kenneth Dipietro's CIK is 0001540188

Past Insider Trading and Trends

2015 was Kenneth Dipietro's most active year for acquiring shares with 6 total transactions. Kenneth Dipietro's most active month to acquire stocks was the month of January. 2017 was Kenneth Dipietro's most active year for disposing of shares, totalling 12 transactions. Kenneth Dipietro's most active month to dispose stocks was the month of January. 2016 saw Kenneth Dipietro paying a total of $674,327.70 for 16,784 shares, this is the most they've acquired in one year. In 2015 Kenneth Dipietro cashed out on 13,424 shares for a total of $2,449,373.89, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

BIOGEN INC. (BIIB) Snapshot price: $241.66

EVP Human Resources

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+82.30%
3.24K
$278.66
-$684,399.16
7.18K
Feb 28
Form 4
—
0
—
—
0
Feb 15
Form 4
+9.33%
336
$258.99
-$77,697.00
3.94K
Feb 23
Form 4
—
0
—
—
0
Feb 22
Form 4
+117.71%
1.95K
$247.22
-$338,444.18
3.6K
Feb 12
Form 4/A
∞
2.47K
—
—
2.47K
Feb 1
Form 4
∞
1.65K
$273.45
$452,286.30
1.65K
Feb 1
Form 4
-100.00%
-803.00
$415.46
-$333,614.38
0
Scheduled
Mar 16
Form 4
—
0
—
—
0
Feb 23
Form 4
-59.67%
-1.19K
$389.11
-$462,262.68
803
Scheduled
Feb 17
Form 4
∞
1.99K
$392.11
-$695,211.03
1.99K
Feb 12
Form 4
-100.00%
-1.66K
$389.03
-$644,233.68
0
Scheduled
Feb 2
Form 4
∞
1.66K
$389.16
-$314,052.12
1.66K
Feb 1
Form 4
—
0
$319.46
-$717,511.14
0
Scheduled
Feb 12 - Feb 13
Form 4
-100.00%
-1.66K
$299.01
-$494,861.55
0
Scheduled
Feb 4
Form 4
∞
1.66K
$312.64
-$252,613.12
1.66K
Feb 1
Form 4
-100.00%
-1.44K
$242.00
-$348,480.00
0
Scheduled
Sep 30
Form 4
—
0
—
—
0
Feb 12
Form 4
∞
1.44K
$157.30
-$111,840.30
1.44K
Feb 1
Form 4
—
0
—
—
0
Feb 1
Form 3
—
0
—
—
0
No matching records found

Cerevel Therapeutics Holdings, Inc. (CERE) Snapshot price: $41.555

Chief Human Resources Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 19
Form 4
—
0
$22.48
-$303,608.00
24.66K
Dec 22
Form 4
+45.03%
7.66K
$41.42
-$259,143.54
24.66K
Dec 19 - Dec 20
Form 4
—
0
—
—
0
Feb 6
Form 4
—
0
—
—
0
Feb 9
Form 4
—
0
—
—
0
Feb 3
Form 3
—
0
—
—
0
No matching records found

INVIVO THERAPEUTICS HOLDINGS CORP. (NVIV) Snapshot price: $0.608999

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 19
Form 4
—
0
—
—
0
Jan 18
Form 4
—
0
—
—
0
Dec 10
Form 4
—
0
—
—
0
Jul 31
Form 4
—
0
—
—
0
Dec 10
Form 4
—
0
—
—
0
Dec 10
Form 4
—
0
—
—
0
Dec 18
Form 3
—
0
—
—
0
No matching records found